论文部分内容阅读
(1)干扰素 近来有了对乙型肝炎应用白细胞干扰素 (以下简称HLIF)治疗,驱逐HBV(乙型肝炎病毒)有效的报告。不过,对乙型肝炎HLIF疗法的有效性和用干扰素(以下简称I.F)为主的非特异性抗病毒物质对于乙型肝炎慢性化和予后的关系,则至今还未定论。这里我们仅就抗病毒物质对肝炎慢性化和予后的关系进行分析研究:我们分析血中I.F值,I.F以外的非特异抗病毒物质(以下简称AVS),由病毒诱导淋巴细胞产生的I.F值等加以探讨,并且还对HBsAg(乙型肝炎类表面抗原)阳性的5例病人给予各种剂量的HLIF,探讨它们的疗效。 方法:将研究对象全部入院,并且(一)研究对象:对HBsAg阳性者,使用腹腔镜、
(1) Interferon Recently, there has been a report on the effective treatment of hepatitis B virus (Hepatitis B virus) for the treatment of hepatitis B patients with leukocyte interferon (hereinafter referred to as HLIF). However, the effectiveness of the treatment of hepatitis B virus HLIF and interferon (hereinafter referred to as I. F) -based non-specific antiviral substance for chronic hepatitis B and postponed the relationship has not yet been conclusive. Here, we only analyze the relationship between anti-viral substances chronic hepatitis and post-grant: we analyzed the IF value in blood, non-specific antiviral substance other than IF (hereinafter referred to as AVS), IF induced by virus-induced lymphocytes Et al., And also investigated the efficacy of various doses of HLIF on 5 patients who were positive for HBsAg (hepatitis B surface antigen). Methods: All subjects were admitted to the hospital, and (a) research object: HBsAg positive, the use of laparoscopy,